To determine the impact of recombinant luteinizing hormone ( rLH ) combined with vaginal progesterone ( P ) for luteal supplementation on in vitro fertilization ( IVF ) pregnancy outcomes in high-responder patients undergoing long gonadotropin-releasing hormone ( GnRH ) agonist cycles .